4,6-Dihydroxy-2-methylpyrimidine-5-carbaldehyde

Catalog No. :
ACRGJY519
CAS No. :
14160-85-1
Molecular Formula :
C6H6N2O3
Molecular Weight :
154.13

IUPAC Name:4,6-dihydroxy-2-methylpyrimidine-5-carbaldehyde

4,6-Dihydroxy-2-methylpyrimidine-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$56.00Login to see priceIn stockInquiry
5g95%$146.00Login to see priceIn stockInquiry
25g95%$715.00Login to see priceIn stockInquiry
100g95%$2188.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,6-Dihydroxy-2-methylpyrimidine-5-carbaldehyde
IUPAC Name4,6-dihydroxy-2-methylpyrimidine-5-carbaldehyde
MDL No.MFCD01791182
Molecular FormulaC6H6N2O3
Molecular Weight154.13
SMILESCC1=NC(O)=C(C=O)C(O)=N1
InChI KeyLRVSBYJDLSIFGG-UHFFFAOYSA-N
Synonym4,6-Dihydroxy-2-methylpyrimidine-5-carbaldehyde ,97%;5-Pyrimidinecarboxaldehyde, 1,6-dihydro-4-hydroxy-2-methyl-6-oxo-;4,6-Dihydroxy-2-methylpyrimidine-5-carbaldehyde ,97% ISO 9001:2015 REACH
CAS No.14160-85-1
PubChem CID1078070

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRGJY519 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDNGK763 route compound structure diagram
    ACDNGK7631194-22-5 In Stock
  4. Then
  5. ACRGJY519 route product structure diagram
    ACRGJY51914160-85-1 In Stock
Inquiry

2. ACRGJY519 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRGJY519 route product structure diagram
    ACRGJY51914160-85-1 In Stock
Inquiry

Comments (0)